Share Price:

APNASPENAspen Pharmacare Hldgs23507-28 (-0.12%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Regional Overviews

Aspen in Europe CIS

The Europe CIS region offers a diverse array of Sterile Focus and Regional Brands and engages in third‑party manufacturing. Within the revenue mix, the contribution from the Sterile Focus Brands portfolio ranks as the second highest, trailing behind Asia. This portfolio primarily includes Anaesthetics and, to a lesser extent, Thrombosis products in both Russia and the broader Europe CIS region. The manufacturing operations in this region encompass API and FDF production, are widely accredited and provide a variety of technologies for
Aspen’s own commercialisation strategy and for third-party use.

Key Countries

France
Germany
Ireland
Netherlands
Russian Federation

Overview

Brand Therapeutic category

Emla

Local anaesthetic

Fraxiparine

Low molecular weight heparin

Ovestin

Estrogen hormone replacement

Ultiva

Injectable general anaesthetic

Xylocaine

Regional anaesthetic

Products
Launched

(2022: Nil)

0
Product
Recalls

(2022: 5)

0 %
Average Staff
Turnover

(2022: 9%)

Work-related
Facilities

(2022: Nil)

50
Sales
Representatives

(2022: 140)

900
Permanent
Employees

(June 2022: 2,192)

Revenue 2023
R’million
2022 (CER)
R’million
Change
%

Commercial Pharmaceuticals

4 847

5 206

(7)

Regional Brands

1 774

1 740

2

Sterile Focus Brands

3 073

3 466

(11)

Manufacturing

9 790

9 132

7

API

4 832

5 128

(6)

FDF - Steriles

1 037

1 007

3

FDF - Other

498

414

20

Heparin

3 423

2 583

33

Total

14 637

14 338

2

Note: Commercial Pharmaceuticals revenue is by customer geography and manufacturing revenue by place of manufacture.

Contribution to Group revenue (%)
Revenue by segment (%)

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.